Genome-wide binding of MBD2 reveals strong preference for highly methylated loci

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Menafra, Roberta ^a   Brinkman, Arie B ^a   Matarese, Filomena ^a   Franci, Gianluigi ^a   Bartels, Stefanie J J ^a   Nguyen, Luan ^a   Shimbo, Takashi ^b   Wade, Paul A ^b   Hubner, Nina C ^a   Stunnenberg, Hendrik G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; DNA; METHYL CPG BINDING PROTEIN 2; RNA POLYMERASE II; DNA BINDING PROTEIN; MBD2 PROTEIN, HUMAN;

AMINO TERMINAL SEQUENCE; ARTICLE; BCL11B GENE; BEND3 GENE; BINDING SITE; BREAST CANCER; C1QBP GENE; CASZ1 GENE; CDK2AP1 GENE; CHD3 GENE; CHD4 GENE; CONTROLLED STUDY; CPG ISLAND; CTBP2 GENE; CUX1 GENE; DNA METHYLATION; GATAD2A GENE; GATAD2B GENE; GENE; GENE AMPLIFICATION; GENE EXPRESSION; GENE INTERACTION; HDAC1 GENE; HDAC2 GENE; HUMAN; HUMAN CELL; IN VIVO STUDY; MCF 7 CELL LINE; MECOM GENE; MOLECULAR CLONING; MTA1 GENE; MTA3 GENE; NUCLEOTIDE SEQUENCE; PGBD3 GENE; POLYMERASE CHAIN REACTION; PROTEIN BINDING; PRR12 GENE; RBBP4 GENE; TRPS1 GENE; ZBTB10 GENE; ZBTB7B GENE; ZNF219 GENE; ZNF512B GENE; BREAST TUMOR; CHEMISTRY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; PROMOTER REGION; SEQUENCE ANALYSIS;

BINDING SITES; BREAST NEOPLASMS; CPG ISLANDS; DNA METHYLATION; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; RNA POLYMERASE II; SEQUENCE ANALYSIS, RNA;

EID: 84903140408     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099603     Document Type: Article

References (43)

1. Ariel M, Robinson E, McCarrey JR, Cedar H (1995) Gamete-specific methylation correlates with imprinting of the murine Xist gene. Nature genetics 9: 312-315.
2. Holliday R, Pugh JE (1975) DNA modification mechanisms and gene activity during development. Science 187: 226-232.
3. Wutz A, Smrzka OW, Schweifer N, Schellander K, Wagner EF, et al. (1997) Imprinted expression of the Igf2r gene depends on an intronic CpG island. Nature 389: 745-749. (Pubitemid 27458963)
4. Feinberg AP, Vogelstein B (1983) Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301: 89-92. (Pubitemid 13154475)
5. Robertson KD, Jones PA (2000) DNA methylation: past, present and future directions. Carcinogenesis 21: 461-467. (Pubitemid 30137931)
6. Bird AP (1986) CpG-rich islands and the function of DNA methylation. Nature 321: 209-213.
7. Mohn F, Weber M, Rebhan M, Roloff TC, Richter J, et al. (2008) Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. Molecular cell 30: 755-766.
8. Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nature reviews Genetics 3: 415-428. (Pubitemid 34587077)
9. Deaton AM, Bird A (2011) CpG islands and the regulation of transcription. Genes & development 25: 1010-1022.
10. Hellman A, Chess A (2007) Gene body-specific methylation on the active X chromosome. Science 315: 1141-1143. (Pubitemid 46328027)
11. Wolf SF, Jolly DJ, Lunnen KD, Friedmann T, Migeon BR (1984) Methylation of the hypoxanthine phosphoribosyltransferase locus on the human X chromosome: implications for X-chromosome inactivation. Proceedings of the National Academy of Sciences of the United States of America 81: 2806-2810. (Pubitemid 14123803)
12. Ball MP, Li JB, Gao Y, Lee JH, LeProust EM, et al. (2009) Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nature biotechnology 27: 361-368.
13. Klose RJ, Bird AP (2006) Genomic DNA methylation: the mark and its mediators. Trends in biochemical sciences 31: 89-97. (Pubitemid 43221841)
14. Fournier A, Sasai N, Nakao M, Defossez PA (2012) The role of methyl-binding proteins in chromatin organization and epigenome maintenance. Briefings in functional genomics 11: 251-264.
15. Laget S, Joulie M, Le Masson F, Sasai N, Christians E, et al. (2010) The human proteins MBD5 and MBD6 associate with heterochromatin but they do not bind methylated DNA. PloS one 5: e11982.
16. Barr H, Hermann A, Berger J, Tsai HH, Adie K, et al. (2007) Mbd2 contributes to DNA methylation-directed repression of the Xist gene. Molecular and cellular biology 27: 3750-3757. (Pubitemid 46726182)
17. Zhang Y, Ng HH, Erdjument-Bromage H, Tempst P, Bird A, et al. (1999) Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes & development 13: 1924-1935. (Pubitemid 29407360)
18. Zhu D, Hunter SB, Vertino PM, Van Meir EG (2011) Overexpression of MBD2 in glioblastoma maintains epigenetic silencing and inhibits the antiangiogenic function of the tumor suppressor gene BAI1. Cancer research 71: 5859-5870.
19. Martin V, Jorgensen HF, Chaubert AS, Berger J, Barr H, et al. (2008) MBD2-mediated transcriptional repression of the p14ARF tumor suppressor gene in human colon cancer cells. Pathobiology: journal of immunopathology, molecular and cellular biology 75: 281-287.
20. Stefanska B, Suderman M, Machnes Z, Bhattacharyya B, Hallett M, et al. (2013) Transcription onset of genes critical in liver carcinogenesis is epigenetically regulated by methylated DNA-binding protein MBD2. Carcinogenesis 34: 2738-2749.
21. Le Guezennec X, Vermeulen M, Brinkman AB, Hoeijmakers WA, Cohen A, et al. (2006) MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties. Molecular and cellular biology 26: 843-851. (Pubitemid 43146480)
22. Hendrich B, Bird A (1998) Identification and characterization of a family of mammalian methyl-CpG binding proteins. Molecular and cellular biology 18: 6538-6547. (Pubitemid 28500543)
23. Gunther K, Rust M, Leers J, Boettger T, Scharfe M, et al. (2013) Differential roles for MBD2 and MBD3 at methylated CpG islands, active promoters and binding to exon sequences. Nucleic acids research 41: 3010-3021.
24. Baubec T, Ivanek R, Lienert F, Schubeler D (2013) Methylation-dependent and -independent genomic targeting principles of the MBD protein family. Cell 153: 480-492.
25. Costessi A, Mahrour N, Sharma V, Stunnenberg R, Stoel MA, et al. (2012) The human EKC/KEOPS complex is recruited to Cullin2 ubiquitin ligases by the human tumour antigen PRAME. PLoS One 7: e42822.
26. Hubner NC, Bird AW, Cox J, Splettstoesser B, Bandilla P, et al. (2010) Quantitative proteomics combined with BAC TransgeneOmics reveals in vivo protein interactions. The Journal of cell biology 189: 739-754.
27. Tian B, Yang J, Brasier AR (2012) Two-step cross-linking for analysis of protein-chromatin interactions. Methods in molecular biology 809: 105-120.
28. Feng J, Liu T, Qin B, Zhang Y, Liu XS (2012) Identifying ChIP-seq enrichment using MACS. Nature protocols 7: 1728-1740.
29. Habibi E, Brinkman AB, Arand J, Kroeze LI, Kerstens HH, et al. (2013) Whole-genome bisulfite sequencing of two distinct interconvertible DNA methylomes of mouse embryonic stem cells. Cell stem cell 13: 360-369.
30. Vakoc CR, Mandat SA, Olenchock BA, Blobel GA (2005) Histone H3 lysine 9 methylation and HP1gamma are associated with transcription elongation through mammalian chromatin. Molecular cell 19: 381-391. (Pubitemid 41074893)
31. Brinkman AB, Roelofsen T, Pennings SW, Martens JH, Jenuwein T, et al. (2006) Histone modification patterns associated with the human X chromosome. EMBO reports 7: 628-634. (Pubitemid 43827331)
32. Baubec T, Ivánek R, Lienert F, Schübeler D (2013) Methylation-Dependent and -Independent Genomic Targeting Principles of the MBD Protein Family. Cell 153: 480-492.
33. Komarnitsky P, Cho EJ, Buratowski S (2000) Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription. Genes Dev 14: 2452-2460.
34. Jonkers I, Kwak H, Lis JT (2014) Genome-wide dynamics of Pol II elongation and its interplay with promoter proximal pausing, chromatin, and exons. eLife.
35. Veloso A, Kirkconnell KS, Magnuson B, Biewen B, Paulsen MT, et al. (2014) Rate of elongation by RNA polymerase II is associated with specific gene features and epigenetic modifications. Genome Res.
36. Hon GC, Hawkins RD, Caballero OL, Lo C, Lister R, et al. (2012) Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer. Genome Res 22: 246-258.
37. Ruike Y, Imanaka Y, Sato F, Shimizu K, Tsujimoto G (2010) Genome-wide analysis of aberrant methylation in human breast cancer cells using methyl-DNA immunoprecipitation combined with high-throughput sequencing. BMC Genomics 11: 137.
38. Costessi A, Mahrour N, Tijchon E, Stunnenberg R, Stoel MA, et al. (2011) The tumour antigen PRAME is a subunit of a Cul2 ubiquitin ligase and associates with active NFY promoters. The EMBO journal 30: 3786-3798.
39. Smits AH, Jansen PW, Poser I, Hyman AA, Vermeulen M (2013) Stoichiometry of chromatin-associated protein complexes revealed by label-free quantitative mass spectrometry-based proteomics. Nucleic acids research 41: e28.
40. Hubner NC, Mann M (2011) Extracting gene function from protein-protein interactions using Quantitative BAC InteraCtomics (QUBIC). Methods 53: 453-459.
41. Cox J, Mann M (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nature biotechnology 26: 1367-1372.
42. Shimbo T, Du Y, Grimm SA, Dhasarathy A, Mav D, et al. (2013) MBD3 Localizes at Promoters, Gene Bodies and Enhancers of Active Genes. PLoS genetics 9: e1004028.
43. Ovaska K, Matarese F, Grote K, Charapitsa I, Cervera A, et al. (2013) Integrative analysis of deep sequencing data identifies estrogen receptor early response genes and links ATAD3B to poor survival in breast cancer. PLoS computational biology 9: e1003100.